More than 20% of sarcoidosis patients show signs of an immune system response against aluminum, beryllium, zirconium, and silica, supporting the idea that these compounds may be involved in the development of the disease in a subgroup of patients, according to findings from a research study. The study, “…
Sarcoidosis patients who more closely follow their established treatment plans were found to have a significantly improved health-related quality of life, a new observational study shows. The study, “Association of Medication Adherence and Clinical Outcomes in Sarcoidosis,” which was published in the journal Chest, is…
Sarcoidosis, and the medications prescribed to patients with the disease, do not lead to worse outcomes from COVID-19 infection, according to preliminary results of a survey conducted by the Foundation for Sarcoidosis Research (FSR). Though more participants are needed to confirm the results, the data are noteworthy…
The Foundation for Sarcoidosis Research is partnering with the American Lung Association for its sixth annual effort to raise awareness about sarcoidosis and provide resources for patients, caregivers, and clinicians during Sarcoidosis Awareness Month in April, and specifically to address concerns in the midst of the…
Get regular updates to your inbox.